Indivior Pharmaceuticals Inc INDV NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

72/100

5/7 Pass

SharesGrow Intrinsic Value

共有 48 笔近期内部人交易记录记录，涉及 Indivior Pharmaceuticals Inc (INDV), 包括 25 笔买入 和 5 笔卖出. 内部人买入总额为 $203.61K 内部人卖出总额为 RSU 奖励.

近期活跃的重要内部人包括 Barry Patrick A, Ciaffoni Joseph, Burris Jeffrey W. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — INDV

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2028-06-02	Barry Patrick A	Chief Commercial Officer	未知	130,312	-	-	-
2028-05-08	Ciaffoni Joseph	Chief Executive Officer	未知	422,302	-	-	-
2028-03-07	Burris Jeffrey W	Chief Legal Officer	未知	71,743	-	-	-
2028-03-07	Anderson Woodrow D	Chief Accounting Officer	未知	29,478	-	-	-
2028-03-07	Heidbreder Christian	Chief Scientific Officer	未知	82,287	-	-	-
2028-03-07	Preblick Ryan	Chief Financial Officer	未知	70,459	-	-	-
2026-03-14	Preblick Ryan	Chief Financial Officer	期权行权（卖出）	6,302	-	-	-
2026-03-13	Ryan Barbara	Director	知情买入	8	$31.09	$248.68	5,724
2026-03-09	Ryan Barbara	Director	知情买入	31	$32.56	$1.01K	5,716
2026-03-06	Kingsley Stuart A	Director	知情买入	940	$31.87	$29.95K	5,582
2026-03-03	Burris Jeffrey W	Chief Legal Officer	期权行权（卖出）	104,300	-	-	-
2026-03-03	Anderson Woodrow D	Chief Accounting Officer	期权行权（卖出）	5,946	-	-	-
2026-03-03	Heidbreder Christian	Chief Scientific Officer	期权行权（卖出）	132,565	-	-	-
2026-03-03	Preblick Ryan	Chief Financial Officer	期权行权（卖出）	113,510	-	-	-
2026-02-10	Ciaffoni Joseph	Chief Executive Officer	限制性股票授予 (RSU)	79,976	-	-	135,976
2026-02-10	Burris Jeffrey W	Chief Legal Officer	限制性股票授予 (RSU)	26,897	-	-	27,657
2026-02-10	Barry Patrick A	Chief Commercial Officer	限制性股票授予 (RSU)	31,380	-	-	31,380
2026-02-10	Anderson Woodrow D	Chief Accounting Officer	限制性股票授予 (RSU)	6,903	-	-	11,293
2026-02-10	Heidbreder Christian	Chief Scientific Officer	限制性股票授予 (RSU)	33,622	-	-	190,762
2026-02-10	Preblick Ryan	Chief Financial Officer	限制性股票授予 (RSU)	37,358	-	-	317,940
2026-02-09	Burris Jeffrey W	Chief Legal Officer	限制性股票授予 (RSU)	104,300	-	-	104,300
2026-02-09	Anderson Woodrow D	Chief Accounting Officer	限制性股票授予 (RSU)	23,975	-	-	23,975
2026-02-09	Heidbreder Christian	Chief Scientific Officer	限制性股票授予 (RSU)	132,565	-	-	132,565
2026-02-09	Preblick Ryan	Chief Financial Officer	限制性股票授予 (RSU)	113,510	-	-	113,510
2026-01-26	Ninivaggi Daniel A	Director	限制性股票授予 (RSU)	3,722	-	-	20,645
2026-01-26	Kingsley Stuart A	Director	限制性股票授予 (RSU)	3,722	-	-	4,642
2026-01-26	Stejbach Mark	Director	限制性股票授予 (RSU)	3,722	-	-	20,569
2026-01-26	Thompson Juliet	Director	限制性股票授予 (RSU)	3,722	-	-	7,572
2026-01-26	Wheadon David E.	Director	限制性股票授予 (RSU)	5,955	-	-	20,350
2026-01-26	Ryan Barbara	Director	限制性股票授予 (RSU)	3,722	-	-	5,685
2026-01-26	Humphreys Keith	Director	限制性股票授予 (RSU)	3,722	-	-	9,524
2026-01-05	Ninivaggi Daniel A	Director	知情买入	775	$35.39	$27.43K	16,923
2026-01-05	Stejbach Mark	Director	知情买入	775	$35.39	$27.43K	16,847
2026-01-05	Wheadon David E.	Director	知情买入	1,771	$35.39	$62.68K	14,395
2026-01-05	Ryan Barbara	Director	知情买入	775	$35.39	$27.43K	1,963
2026-01-05	Humphreys Keith	Director	知情买入	775	$35.39	$27.43K	5,802
2026-01-01	Ninivaggi Daniel A	Director	未知	-	-	-	16,148
2026-01-01	Kingsley Stuart A	Director	未知	-	-	-	920
2026-01-01	Ciaffoni Joseph	Chief Executive Officer	未知	1,266,903	-	-	-
2026-01-01	Burris Jeffrey W	Chief Legal Officer	未知	-	-	-	760
2026-01-01	Stejbach Mark	Director	未知	-	-	-	16,072
2026-01-01	Thompson Juliet	Director	未知	-	-	-	3,850
2026-01-01	Wheadon David E.	Director	未知	-	-	-	12,624
2026-01-01	Ryan Barbara	Director	未知	-	-	-	1,188
2026-01-01	Anderson Woodrow D	Chief Accounting Officer	未知	-	-	-	4,390
2026-01-01	Heidbreder Christian	Chief Scientific Officer	未知	-	-	-	157,140
2026-01-01	Preblick Ryan	Chief Financial Officer	未知	-	-	-	280,582
2026-01-01	Humphreys Keith	Director	未知	-	-	-	5,027